Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4. (Q33291961)

25 July 2017

title

Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4. (English)

1 reference

25 July 2017

Martin Karplus

1 reference

25 July 2017

Gregory A Weiss

1 reference

25 July 2017

Erik Evensen

1 reference

25 July 2017

Diane Joseph-McCarthy

series ordinal

1 reference

25 July 2017

Stuart L Schreiber

series ordinal

1 reference

25 July 2017

language of work or name

1 reference

27 July 2007

1 reference

Journal of Computer - Aided Molecular Design

25 July 2017

published in

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

395-418

1 reference

Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules

25 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10822-007-9119-X

X-Ray Crystal Structure of HLA-DR4 (DRA*0101, DRB1*0401) Complexed with a Peptide from Human Collagen II

21 January 2018

1 reference

12 December 2020

Invariant chain structure and MHC class II function

1 reference

12 December 2020

Automated generation of MCSS-derived pharmacophoric DOCK site points for searching multiconformation databases

1 reference

12 December 2020

Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule

1 reference

12 December 2020

Structure-based design of nonnatural ligands for the HLA-B27 protein

1 reference

12 December 2020

Fragment-based lead discovery: a chemical update

1 reference

12 December 2020

1 reference

12 December 2020

Use of MCSS to design small targeted libraries: application to picornavirus ligands.

1 reference

12 December 2020

Combinatorial computational method gives new picomolar ligands for a known enzyme

1 reference

12 December 2020

A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation

1 reference

12 December 2020

Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries

1 reference

12 December 2020

Beyond mere diversity: tailoring combinatorial libraries for drug discovery

1 reference

12 December 2020

General method for rapid synthesis of multicomponent peptide mixtures

1 reference

12 December 2020

Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression

1 reference

12 December 2020

NMR-based screening in drug discovery

1 reference

12 December 2020

HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions

1 reference

12 December 2020

Simulation analysis of the stability mutant R96H of T4 lysozyme.

1 reference

12 December 2020

The basis of autoimmunity: Part II. Genetic predisposition

1 reference

12 December 2020

Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.

1 reference

12 December 2020

Combinatorial and computational approaches in structure-based drug design

1 reference

12 December 2020

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

1 reference

12 December 2020

HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

1 reference

12 December 2020

MCSS functionality maps for a flexible protein.

1 reference

12 December 2020

The study of HLA class II and autoimmune diabetes

1 reference

12 December 2020

Functionality maps of binding sites: a multiple copy simultaneous search method

1 reference

12 December 2020

LASSOO: a generalized directed diversity approach to the design and enrichment of chemical libraries

1 reference

12 December 2020

Structure-based discovery and in-parallel optimization of novelcompetitive inhibitors of thymidylate synthase

1 reference

12 December 2020

Current concepts in autoimmune hepatitis

1 reference

12 December 2020

Antigenic peptide binding by class I and class II histocompatibility proteins

1 reference

12 December 2020

Fragment-based lead discovery using X-ray crystallography.

1 reference

12 December 2020

A molecular field-based similarity approach to pharmacophoric pattern recognition.

1 reference

12 December 2020

The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography

1 reference

12 December 2020

Coupling structure-based design with combinatorial chemistry: application of active site derived pharmacophores with informative library design

1 reference

12 December 2020

Disease susceptibility, transplantation and the MHC

1 reference

12 December 2020

Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.

1 reference

12 December 2020

TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex

1 reference

12 December 2020

An automated method for dynamic ligand design.

1 reference

12 December 2020

Map of the human MHC.

1 reference

12 December 2020

Computational combinatorial ligand design: application to human alpha-thrombin.

1 reference

12 December 2020

Accommodating structurally diverse peptides in proteins.

1 reference

12 December 2020

Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules

1 reference

12 December 2020

New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures

1 reference

12 December 2020

Peptide exchange in MHC molecules

1 reference

12 December 2020

Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules

1 reference

12 December 2020

The measurement of molecular diversity: a three-dimensional approach

1 reference

12 December 2020

VMD: visual molecular dynamics

1 reference

12 December 2020

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

1 reference

12 December 2020

A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design

1 reference

12 December 2020

Statistical clustering techniques for the analysis of long molecular dynamics trajectories: analysis of 2.2-ns trajectories of YPGDV.

1 reference

12 December 2020

Comparing Performance of Computational Tools for Combinatorial Library Design

1 reference

12 December 2020

Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus

1 reference

12 December 2020

Autoimmunity: when self-tolerance breaks down.

1 reference

12 December 2020

MHC class-II molecules and autoimmunity

1 reference

12 December 2020

Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules

1 reference

12 December 2020

Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.

1 reference

12 December 2020

Knowledge-based design of target-focused libraries using protein-ligand interaction constraints

1 reference

12 December 2020

The specificity and orientation of a TCR to its peptide-MHC class II ligands

1 reference

12 December 2020

New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.

1 reference

12 December 2020

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3

1 reference

12 December 2020

Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase

1 reference

12 December 2020

Production of soluble MHC class II proteins with covalently bound single peptides

1 reference

12 December 2020

Aspartic protease inhibitors designed from computer-generated templates bind as predicted.

1 reference

12 December 2020

Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis

1 reference

12 December 2020

The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2

1 reference

12 December 2020

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis

1 reference

12 December 2020

Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.

1 reference

12 December 2020

Specificity pockets for the side chains of peptide antigens in HLA-Aw68

1 reference

12 December 2020

Design of libraries to explore receptor sites

1 reference

12 December 2020

The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation

1 reference

12 December 2020

Fragment-Based Drug Discovery

1 reference

12 December 2020

The genetics of HLA-associated disease

1 reference

12 December 2020

Polar hydrogen positions in proteins: Empirical energy placement and neutron diffraction comparison

1 reference

12 December 2020

Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.

1 reference

12 December 2020

Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures

1 reference

12 December 2020

Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions

1 reference

12 December 2020

The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition

1 reference

12 December 2020

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

12 December 2020

Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases

1 reference

12 December 2020

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/S10822-007-9119-X

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/S10822-007-9119-X

Identifiers

DOI

10.1007/S10822-007-9119-X

1 reference

journals/jcamd/EvensenJWSK07

25 July 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

release_bdxn7zifxngarkaitkd7cuj66e

28 January 2021

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bdxn7zifxngarkaitkd7cuj66e

24 November 2022

mapped directly with Wikidata item

1 reference